An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: How applicable are they?

British Journal of Cancer

Volumn 109, Issue 6, 2013, Pages 1498-1503

  Bendifallah, S ^a,b   Canlorbe, G ^a   Raimond, E ^c   Bazire, L ^a   Huguet, F ^a   Graesslin, O ^c   Rouzier, R ^d   Darai, E ^a   Ballester, M ^a  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BRACHYTHERAPY; CALIBRATION; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; DISTANT METASTASIS; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; VALIDATION STUDY;

COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PREDICTIVE VALUE OF TESTS;

EID: 84884591205     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.500     Document Type: Article

References (22)

1. Abu-Rustum NR, Zhou Q, Gomez JD, Alektiar KM, Hensley ML, Soslow RA, Levine DA, Chi DS, Barakat RR, Iasonos A (2010) A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care. Gynecol Oncol 116: 399-403.
2. Awtrey CS (2012) Nomograms for predicting endometrial cancer recurrence. Gynecol Oncol 125: 513-514.
3. Ballester M, Dubernard G, Lécuru F, Heitz D, Mathevet P, Marret H, Querleu D, Golfier F, Leblanc E, Rouzier R, Darai E (2011) Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: A prospective multicentre study (SENTI-ENDO). Lancet Oncol 12: 469-476.
4. Bendifallah S, Genin AS, Naoura I, Chabbert Buffet N, Clavel Chapelon F, Haddad B, Luton D, Darai E, Rouzier R, Koskas M (2012) A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol 207: 197-198.
5. Benedetti Panici PB, Basile S, Maneschi F (2008) Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst 100: 1707-1716.
6. Chun FK, Karakiewicz PI, Briganti A, Gallina A, Kattan MW, Montorsi F, Huland H, Graefen M (2006) Prostate cancer nomograms: An update. Eur Urol 50: 914-926.
7. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C (2011) ESMO Guidelines Working GroupEndometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22: 35-39.
8. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group study. Cancer 60: 2035-2041.
9. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Cancer Incidence and Mortality World-wide: IARC Cancer Base No. 10. International Agency for Research on Cancer: Lyon, France.
10. Fujimoto T, Nanjyo H, Fukuda J, Nakamura A, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A, Tanaka T (2009) Endometrioid uterine cancer: Histopathological risk factors of local and distant recurrence. Gynecol Oncol 112: 342-347.
11. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
12. Isariyawongse BK, Kattan MW (2012) Prediction tools in surgical oncology. Surg Oncol Clin N Am 21: 439-447.
13. Karolewski K, Kojs Z, Urbanski K, Jakubowicz J, Blecharz P, Dymek P, Reinfuss M (2006) The efficiency of treatment in patients with uterine-confined endometrial cancer. Eur J Gynaecol Oncol 27: 579-584.
14. Kattan MW (2008) Nomograms are difficult to beat. Eur Urol 53: 671-672.
15. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomized study. Lancet 373: 125-136.
16. Kondalsamy-Chennakesavan S, Yu C, Kattan MW, Leung Y, Sykes P, Nascimento M, Nicklin J, Perrin L, Crandon A, Chetty N, Land R, Garrett A, Obermair A (2012) Nomograms to predict isolated locoregional or distant recurrence among women with uterine cancer. Gynecol Oncol 125: 520-525.
17. Koskas M, Bendifallah S, Lutton D, Emile D, Rouzier R (2011) Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer. Gynecol Oncol 123: 214-220.
18. Mariani A, Webb MJ, Keeney GL, Lesnick TG, Podratz KC (2002) Surgical stage I endometrial cancer: Predictors of distant failure and death. Gynecol Oncol 87: 274-280.
19. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1999) Relationship between surgical pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 40: 55-65.
20. Petru E, Luck HJ, Stuart G, Gaffney D, Millan D, Vergote I (2009) Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 143: 69-74.
21. Querleu D, Planchamp F, Narducci F, Morice P, Joly F, Genestie C, Haie-Meder C, Thomas L, Quénel-Tueux N, Darai E, Dorangeon PH, Marret H, Taieb S, Mazeau-Woynar V (2011) Institut National du cancer, Société francise d'oncologie gynécologique. Int J Gynecol Cancer 21: 945-950.
22. Sears JD, Greven KM, Hoen HM, Randall ME (1994) Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 74: 1303-1308.